Mortality effect of albumin fluid resuscitation in adults with septic shock: a systematic review and dual frequentist–bayesian meta-analysis of randomised trials

Read full text
Authors: Henrique Gomes Mendes, Henry Kinkei Wen, Harry de Souza, Yuanyuan Peng, Kush Deshpande, Siebe G. Blok, Pieter R. Tuinman, Ary Serpa Neto, Marcus J. Schultz, Manu L. N. G. Malbrain, Giacomo Grasselli, Frank M.P. van Haren
Cited by: 1
References: 61

Abstract

OBJECTIVE: To determine the effect of albumin-based fluid resuscitation on mortality in adults with septic shock. DESIGN: Systematic review and dual frequentist-Bayesian meta-analysis of randomised clinical trials (RCTs), following PRISMA guidelines and preregistered protocol (CRD420261325998). DATA SOURCES: PubMed, Embase, CENTRAL, and Scopus were searched from inception to February 2026. METHODS: Eligible RCTs comparing albumin-based resuscitation strategies versus crystalloid-based resuscitation in adults with septic shock were included. The primary outcome was all-cause mortality at the longest available follow-up (up to 90 days). The analysis utilised random-effects models, subgroup analyses, and Bayesian methods. RESULTS: Seven trials (n = 3273) were included. Three trials primarily recruited septic shock patients, while data from the remaining were derived from subgroups or extracted strata. At the longest available follow-up, albumin-based fluid resuscitation was associated with a statistically significant 10% reduction in the relative risk of all-cause mortality (RR 0.90, 95% CI 0.83-0.99; p = 0.02; I² = 0%). Bayesian analysis under the primary weakly informative prior yielded a posterior probability of mortality reduction of 94.7% (P[RR < 1.0]). Pre-specified subgroup analyses by albumin formulation, dosing strategy, and trial-level baseline serum albumin did not show evidence of effect modification. CONCLUSION: In adults with septic shock, albumin-based resuscitation strategies are associated with a statistically significant reduction in mortality at the longest available follow-up, with a directionally concordant Bayesian estimate. A mortality benefit is therefore plausible, but the supporting evidence is indirect and imprecise (GRADE: low certainty). Adequately powered trials specifically addressing albumin fluid resuscitation in septic shock are warranted.

Fields of Study & Subjects

Trauma Hemostasis Coagulopathy Resuscitation Sepsis Diagnosis and Treatment Acute Kidney Injury Research

Publication details

Journal / source
Critical Care
Publisher
Springer Science and Business Media LLC
Volume
30
Issue
1
Publication date
6 July 2026
Language
EN